With an experience of more than 37 years in Medical Oncology, Dr. Doval is the epitome of dedication. He specializes in the treatment of solid tumors, with a particular focus on patients with breast and lung cancers. An academically oriented researcher and physician, Dr. Doval has been involved in more than 60 clinical studies. A pioneer in his field, Dr. Doval is guiding Mestastop by providing the valuable clinician perspective.
Nexus Venture Partners
“Arnab’s passion to solve this problem is admirable”
Dr. D.C Doval
“If Mestastop can predict metastasis probability of primary cancer patients, that will be a game changer for doctors”
Dr. A. K Vaid
“Mestastop provides a great opportunity at finding solutions to the unmet medical needs in cancer care”